In a significant move for drug policy reform, Massachusetts voters will have the chance to legalize certain psychedelics this November. The Secretary of the Commonwealth, William F. Galvin, has certified that activists collected enough valid signatures to place the Natural Psychedelic Substances Act on the ballot.
The proposed measure would allow adults 21 and older to possess, grow, and share specific amounts of psychedelics, including DMT, non-peyote mescaline, ibogaine, psilocybin, and psilocin. It also outlines plans for a regulatory commission and licensed service centers.
Despite the legislature’s Special Joint Committee on Ballot Initiatives recommending against the measure, citing concerns about widespread recreational use, supporters argue that psychedelics offer promising therapeutic benefits, particularly for veterans and those with mental health conditions.
If passed, Massachusetts would join a growing number of jurisdictions exploring psychedelic reform, potentially reshaping the landscape of mental health treatment and drug policy. For more details, visit Marijuana Moment.